The Microbiome’s Time To Shine

Exclusive Interview With Seventure CEO Isabelle de Cremoux

In this installment of our VC Playbook series, In Vivo sits down with Isabelle de Cremoux, CEO of Seventure. The company has been a pioneer investor in the microbiome space, which Cremoux believes has now reached a turning point.

• Source: Alamy

Paris-based Seventure Partners established its life sciences team back in 2001 and specializes in the convergence of the health and nutrition sectors. Its focus is on the microbiome, which the company designated as a key area for development in 2008, marking the group as an early mover in this space.

The microbiome sector has grown exponentially in recent years, with Seventure CEO Isabelle de Cremoux telling In Vivo, “2020 was...

More from Leadership

More from In Vivo